| Literature DB >> 24004668 |
Tobias Petzold1, Raphael Ruppert, Dharmendra Pandey, Verena Barocke, Hannelore Meyer, Michael Lorenz, Lin Zhang, Wolfgang Siess, Steffen Massberg, Markus Moser.
Abstract
Integrins are critical for platelet adhesion and aggregation during arterial thrombosis and hemostasis. Although the platelet-specific αIIbβ3 integrin is known to be crucial for these processes, the in vivo role of β1 integrins is a matter of debate. Here we demonstrate that mice expressing reduced levels of β1 integrins or an activation-deficient β1 integrin show strongly reduced platelet adhesion to collagen in vitro and in a carotis ligation model in vivo. Interestingly, hypomorphic mice expressing only 3% of β1 integrins on platelets show normal bleeding times despite reduced platelet adhesion. The residual 3% of β1 integrins are able to trigger intracellular signals driving Rac-1-dependent granule release required for platelet aggregation and hemostasis. Our findings support a model, in which platelet β1 integrins serve as an important signaling receptor rather than an adhesion receptor in vivo and therefore promote β1 integrins as a promising and so far clinically unemployed antithrombotic target.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24004668 DOI: 10.1182/blood-2013-06-508721
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113